Coverage
Filings
Danish vaccine maker Bavarian Nordic will supply an undisclosed European country with its smallpox and mpox vaccine under a new contract valued at over 200 million Danish Krone, the company announced Wednesday.
Danish vaccine company Bavarian Nordic has entered an agreement to sell a Priority Review Voucher for a total of $160 million, the company said Wednesday.
| Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine | 6 Mar 2018 |
| Bavarian Nordic Announces Collaboration to Evaluate CV301 in Combination with durvalumab in Colorectal and Pancreatic Cancers | 26 Feb 2018 |
| Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine | 6 Feb 2018 |
| Bavarian Nordic Announces the Planned Departure of Chief Financial Officer, Ole Larsen | 31 Jan 2018 |
| Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis | 19 Jan 2018 |